When scientists removed the ability of certain brain cells in mice to make acetylcholine, the mice started eating way more and gained weight — but they didn’t move less or burn fewer calories at first.
Scientific Claim
In mice, genetic ablation or conditional knockout of choline acetyltransferase in the diagonal band of Broca leads to a 55–72% reduction in cholinergic neuron markers and is associated with hyperphagia and weight gain, without immediate changes in energy expenditure.
Original Statement
“Counts of ChAT-immunopositive neurons... showed a 72% and 55% decrease in ChAT expression... Cre-expressing animals displayed increased food intake (Fig. 2m) and subsequent weight gain (Fig. 2n)... overall levels of activity and oxygen consumption were unaffected during early stages post-DBB ablation.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study shows association between ChAT reduction and weight gain, but cannot prove causation due to lack of full randomization/blinding and potential off-target effects of viral constructs.
More Accurate Statement
“In mice, genetic ablation or conditional knockout of choline acetyltransferase in the diagonal band of Broca is associated with a 55–72% reduction in cholinergic neuron markers and is associated with hyperphagia and weight gain, without immediate changes in energy expenditure.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bWhether targeted reduction of ChAT expression in DBB cholinergic neurons causally leads to hyperphagia and weight gain independent of confounding variables.
Whether targeted reduction of ChAT expression in DBB cholinergic neurons causally leads to hyperphagia and weight gain independent of confounding variables.
What This Would Prove
Whether targeted reduction of ChAT expression in DBB cholinergic neurons causally leads to hyperphagia and weight gain independent of confounding variables.
Ideal Study Design
A double-blind, randomized trial in 60 Chat-cre+/− mice, randomized to receive AAV-Cre or AAV-GFP in the DBB, with daily food intake, body weight, activity, and VO2 measured for 8 weeks, and ChAT expression quantified post-mortem in a blinded manner.
Limitation: Still limited to mice; cannot determine if this applies to humans or other neuromodulatory systems.
Prospective Cohort StudyLevel 2bWhether the degree of ChAT reduction in the DBB predicts the magnitude of weight gain over time in mice.
Whether the degree of ChAT reduction in the DBB predicts the magnitude of weight gain over time in mice.
What This Would Prove
Whether the degree of ChAT reduction in the DBB predicts the magnitude of weight gain over time in mice.
Ideal Study Design
A prospective cohort of 80 mice with graded ChAT knockdown (via titrated AAV-Cre doses), measuring ChAT expression (IHC), daily food intake, and body weight weekly for 12 weeks to establish a dose-response relationship.
Limitation: Cannot rule out compensatory mechanisms or non-cholinergic effects of viral expression.
Case-Control StudyLevel 3bWhether mice with DBB ChAT knockout show distinct metabolic profiles compared to controls before and after weight gain.
Whether mice with DBB ChAT knockout show distinct metabolic profiles compared to controls before and after weight gain.
What This Would Prove
Whether mice with DBB ChAT knockout show distinct metabolic profiles compared to controls before and after weight gain.
Ideal Study Design
A case-control study comparing 25 ChAT-knockout mice with 25 controls, measuring metabolic parameters (leptin, insulin, glucose, fat mass) at 3 days, 3 weeks, and 3 months post-knockdown, with blinded analysis.
Limitation: Cannot determine if metabolic changes are cause or consequence of obesity.
Animal Study (Cross-Sectional)Level 4Whether ChAT expression levels in the DBB correlate with food intake and body weight in a population of genetically diverse mice.
Whether ChAT expression levels in the DBB correlate with food intake and body weight in a population of genetically diverse mice.
What This Would Prove
Whether ChAT expression levels in the DBB correlate with food intake and body weight in a population of genetically diverse mice.
Ideal Study Design
A cross-sectional study measuring ChAT immunoreactivity in the DBB of 100 wild-type mice with natural variation in body weight and food intake, controlling for sex, age, and diet, to assess correlation strength.
Limitation: Only shows association, not causation.
In Vitro StudyLevel 5Whether loss of ChAT in isolated cholinergic neurons reduces acetylcholine synthesis and release in culture.
Whether loss of ChAT in isolated cholinergic neurons reduces acetylcholine synthesis and release in culture.
What This Would Prove
Whether loss of ChAT in isolated cholinergic neurons reduces acetylcholine synthesis and release in culture.
Ideal Study Design
An in vitro study using primary cultures of basal forebrain neurons from Chat-cre mice, transduced with AAV-Cre or control, measuring acetylcholine release via HPLC and ChAT activity via enzymatic assay.
Limitation: Does not reflect in vivo circuit dynamics or behavioral outcomes.
Evidence from Studies
Supporting (1)
A cholinergic basal forebrain feeding circuit modulates appetite suppression
When scientists blocked a specific brain signal (acetylcholine) in mice, the mice ate way more and got obese — just like the claim says. So the study backs up the idea that this brain signal helps control how much we eat.